AJP - Endo AJP: Advances in Physiology Education
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 266: E459-E466, 1994;
0193-1849/94 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barragan, J. M.
Right arrow Articles by Blazquez, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barragan, J. M.
Right arrow Articles by Blazquez, E.

AJP - Endocrinology and Metabolism, Vol 266, Issue 3 E459-E466, Copyright © 1994 by American Physiological Society


ARTICLES

Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1-(7-36) amide in rats

J. M. Barragan, R. E. Rodriguez and E. Blazquez
Department of Biochemistry and Molecular Biology, University of Salamanca, Spain.

This study was designed to determine the effects of glucagon-like peptides (GLP) on arterial blood pressure and heart rate. Although glucagon caused a minimal effect and GLP-1-(1-37) produced a moderate increase of both systolic and diastolic blood pressure, GLP-1-(7-36) amide induced the greatest increases in both parameters. Systolic and diastolic blood pressure and heart rate values increased when doses of the peptides were increased. By contrast, GLP-2 did not modify either arterial blood pressure or heart rate values. To determine whether the effects of GLP-1-(7-36) amide were mediated through catecholamines, the rats were pretreated with reserpine, propranolol, or phentolamine before administration of the peptide. In these three experimental groups, GLP-1-(7-36) amide increases mean arterial blood pressure and heart rate to the same level or even greater than that observed in nonpretreated rats. These findings indicate that GLP-1-(7-36) amide significantly increases arterial blood pressure and heart rate and that these effects are not mediated through catecholamines.


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. J. Swoap, C. Li, J. Wess, A. D. Parsons, T. D. Williams, and J. M. Overton
Vagal tone dominates autonomic control of mouse heart rate at thermoneutrality
Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1581 - H1588.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. L. Sowden, D. J. Drucker, D. Weinshenker, and S. J. Swoap
Oxyntomodulin increases intrinsic heart rate in mice independent of the glucagon-like peptide-1 receptor
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R962 - R970.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. A. Nikolaidis, D. Elahi, Y.-T. Shen, and R. P. Shannon
Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left ventricular performance in conscious dogs with dilated cardiomyopathy
Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2401 - H2408.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
E. M Sinclair and D. J. Drucker
Proglucagon-Derived Peptides: Mechanisms of Action and Therapeutic Potential
Physiology, October 1, 2005; 20(5): 357 - 365.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
X. Qin, H. Shen, M. Liu, Q. Yang, S. Zheng, M. Sabo, D. A. D'Alessio, and P. Tso
GLP-1 reduces intestinal lymph flow, triglyceride absorption, and apolipoprotein production in rats
Am J Physiol Gastrointest Liver Physiol, May 1, 2005; 288(5): G943 - G949.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
T. Nystrom, M. K. Gutniak, Q. Zhang, F. Zhang, J. J. Holst, B. Ahren, and A. Sjoholm
Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease
Am J Physiol Endocrinol Metab, December 1, 2004; 287(6): E1209 - E1215.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
E. VARA, J. ARIAS-DÍAZ, C. GARCIA, J. L. BALIBREA, and E. BLÁZQUEZ
Glucagon-like Peptide-1(7-36) Amide Stimulates Surfactant Secretion in Human Type II Pneumocytes
Am. J. Respir. Crit. Care Med., March 15, 2001; 163(4): 840 - 846.
[Abstract] [Full Text]


Home page
J. Exp. Biol.Home page
T. Uesaka, K. Yano, S. Sugimoto, and M. Ando
Glucagon-like peptide isolated from the eel intestine: effects on atrial beating
J. Exp. Biol., January 9, 2001; 204(17): 3019 - 3026.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. M. Barragan, J. Eng, R. Rodriguez, and E. Blazquez
Neural contribution to the effect of glucagon-like peptide-1-(7---36) amide on arterial blood pressure in rats
Am J Physiol Endocrinol Metab, November 1, 1999; 277(5): E784 - E791.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. G. Vila Petroff, J. M. Egan, X. Wang, and S. J. Sollott
Glucagon-Like Peptide-1 Increases cAMP but Fails to Augment Contraction in Adult Rat Cardiac Myocytes
Circ. Res., August 31, 2001; 89(5): 445 - 452.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online